Consistently, IHC staining for p-Akt, constitutively activated in CRPC cells, showed that downregulation of MYSM1 resulted in a significant increase in p-Akt expression in tumor tissues derived from mice implanted with 22Rv1/shMYSM1 cells (Figure 3D). This evidence concerns the gene MYSM1 and neoplasm.